Drugs / Calcichew D3
Calcichew D3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02457247 | Jun → Aug 2015 | nutritional disorder | Takeda | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcichew D3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02457247 ↗ |
| Known as | Calcichew D3 500/400 | “The drug being tested in this study is called Calcichew D3 new formulations: Calcichew D3 500/400 and Calcichew D3 500/800.” NCT02457247 ↗ |
| Known as | Calcichew D3 500/800 | “The drug being tested in this study is called Calcichew D3 new formulations: Calcichew D3 500/400 and Calcichew D3 500/800.” NCT02457247 ↗ |